April 13 - April 14, 2022 •
23:00 - 0:30
Investment Promotion Program: Life Science and Healthcare
Series presented in conjunction with the Japan Society and JETRO
Register
Speakers
E
Edward Gudaitis, President and CEO, Acerus Pharma
A
Arthur Li, Senior Partnerships Manager, Cyclica Inc.
H
Hemanth Varghese, Senior Vice President, Strategy and Operations, HLS Therapeutics
M
Martin Cho, Head of Patient Value and Access, Takeda Canada
Teresa A. Reguly
Torys, the Japan Society and JETRO are excited to continue its investment promotional program in 2022. This program is designed to showcase Japanese investors with business opportunities in Canada. We will highlight six industries at each webinar featuring innovative Canadian companies.
Life Science and Healthcare
Innovations in health care are critical for improving access to timely treatment, delivery of service and therapeutic options for patients. The life science sector is thriving in Canada, with a large pool of skilled researchers and professionals with extensive expertise, making this industry ripe for investment. In this session, you will hear from companies focusing on the development and commercialization of health products and technologies, driving innovation to improve medical care and contributing to the innovation economy in Canada.
Time: 7:00 – 8:30 p.m. EDT
8:00 – 9:30 a.m. (Thursday, April 14) JST